Suiqing Zhou | liver cancer | Best Researcher Award | 13333

Published on by Research Awards

Dr. Suiqing Zhou | liver cancer | Best Researcher Award 

Dr. Suiqing Zhou, Nanjing Medical University, China

Dr. Suiqing Zhou, a PhD student at Nanjing Medical University, is a clinician-scientist specializing in translational liver cancer research. With extensive experience in both clinical and basic science, Dr. Zhou has contributed significantly to hepatocellular carcinoma studies, serving as a key investigator in multiple national and provincial research projects. Their work has been published in high-impact SCI-indexed journals, advancing knowledge in tumor biology, immunotherapy, and metabolic regulation. Dr. Zhou’s research has directly informed innovative diagnostic and therapeutic strategies, demonstrating a commitment to improving liver cancer outcomes. Their contributions reflect a strong dedication to scientific excellence and medical advancement.

Profile

Scopus

Early Academic Pursuits 🎓

Dr. Suiqing Zhou embarked on an academic journey with a deep-rooted passion for medical sciences, particularly in hepatology and translational cancer research. During their undergraduate years, Dr. Zhou demonstrated exceptional aptitude in biomedical sciences, excelling in coursework and laboratory research. Their keen interest in understanding the complexities of liver diseases led them to pursue advanced studies at Nanjing Medical University, a premier institution known for cutting-edge medical research.

With a strong foundation in clinical medicine and biomedical research, Dr. Zhou continued to expand their expertise by engaging in rigorous doctoral studies. Their PhD research primarily focuses on unraveling the molecular mechanisms of hepatocellular carcinoma (HCC), one of the deadliest forms of liver cancer. By integrating clinical observations with laboratory-based investigations, Dr. Zhou has contributed to significant breakthroughs in understanding cancer metabolism and therapeutic resistance.

Professional Endeavors 💼

As a clinician-scientist, Dr. Zhou seamlessly bridges the gap between medical practice and scientific inquiry. While undergoing extensive clinical training, they also immersed themselves in high-impact research projects, gaining recognition as a Principal Investigator and key contributor to several national and provincial-level research initiatives.

Dr. Zhou’s expertise extends beyond traditional clinical practice; they have played a pivotal role in advancing translational medicine by incorporating cutting-edge technologies such as CRISPR gene editing, omics-based studies, and immune profiling. Their ability to translate laboratory findings into potential therapeutic strategies has led to collaborations with leading hepatology research centers and biotechnology firms.

Contributions and Research Focus 🎡

Dr. Zhou’s research is primarily centered on elucidating the biological pathways that drive hepatocellular carcinoma progression. Key areas of investigation include:

  • Cancer Metabolism and Fatty Acid Biosynthesis: Their research on eIF3f-mediated fatty acid biosynthesis remodeling has provided new insights into tumor malignancy and potential metabolic targets for therapy.
  • Tumor Angiogenesis and Immune Evasion: By studying the role of DGKG in endothelial cells, Dr. Zhou has identified critical mechanisms underlying HCC’s ability to evade immune responses and sustain aggressive growth.
  • Ferroptosis Sensitivity and Immunotherapy Augmentation: Through CRISPR/Cas9 screening, Dr. Zhou’s team has pinpointed TRIM34 as a crucial regulator of ferroptosis sensitivity, paving the way for novel combination therapies to enhance immunotherapy efficacy.
  • Biomarker Discovery and Personalized Medicine: Their research on GFPT2 and CRTC2 as novel biomarkers has opened new avenues for early diagnosis and tailored treatment approaches in HCC.

Dr. Zhou’s impressive publication record (9 SCI-indexed articles) in top-tier journals, including Journal of Hepatology, Cancer Letters, British Journal of Cancer, and Cell Metabolism, underscores the impact of their research in the global scientific community.

Accolades and Recognition 🏆

Dr. Zhou’s contributions to liver cancer research have been met with well-deserved recognition. Their innovative work has led to one published patent (ZL 2021 1 0367998.9, China), signifying their role in developing novel diagnostic and therapeutic solutions.

Beyond research, Dr. Zhou has been actively involved in academic publishing as an editorial board member, further solidifying their reputation as a thought leader in oncology and translational medicine. Invitations to review manuscripts for prestigious medical journals highlight their expertise and influence in the field.

Impact and Influence 🔄

The impact of Dr. Zhou’s research extends beyond publications and patents—it has directly contributed to the refinement of clinical protocols for liver cancer management. Their findings have influenced treatment guidelines and inspired ongoing clinical trials aimed at improving patient outcomes.

Additionally, Dr. Zhou’s role as a mentor and educator has fostered the next generation of medical researchers. By engaging in academic teaching and research supervision, they have guided young scholars in navigating complex biomedical challenges, ensuring a legacy of scientific excellence.

Legacy and Future Contributions 💡

Looking ahead, Dr. Zhou aspires to expand their research on precision oncology, integrating AI-driven diagnostics and targeted therapies into hepatology. Their future endeavors include:

  • Developing Next-Generation Biomarker Panels: Enhancing early detection strategies for liver cancer through advanced molecular profiling.
  • Exploring AI-Driven Drug Discovery: Utilizing artificial intelligence to identify novel drug targets and optimize personalized treatment plans.
  • Expanding Global Collaborations: Partnering with leading hepatology research institutions to accelerate translational research efforts.

Dr. Zhou’s relentless pursuit of knowledge and unwavering commitment to medical innovation position them as a driving force in the field of liver cancer research. With a distinguished career marked by scientific breakthroughs and impactful contributions, their work continues to inspire hope for improved cancer treatments and patient care worldwide.

Publication Top Notes

Endothelial DGKG promotes tumor angiogenesis and immune evasion in hepatocellular carcinoma. Journal of Hepatology

Author: Zhang L, Xu J, Zhou S, Yao F, Zhang R, You W, Dai J, Yu K, Zhang Y, Baheti T, Pu L, Xu J, Qian X, Zhang C, Xia Y, Dai X, Li Q, Wang X.

Journal: Journal of Hepatology

Year: 2024

Establishment of two novel organoid lines from patients with combined hepatocellular cholangiocarcinoma

Author: Y., Gao, Yun, X., Chen, Xiaoyun, Y., Zhu, Yuerong, … L., Pu, Liyong, X., Wang, Xuehao

Journal: Human Cell

Year: 2025




	


	

	






	
	

		


Farheen Jameel | Anticancer | Best Researcher Award | 12810
			

				Published on  by Research Awards			

		
	


	

		
Dr. Farheen Jameel | Anticancer | Best Researcher Award


Dr. Farheen Jameel, University of lucknow, India


Dr. Farheen Jameel is a distinguished researcher from the University of Lucknow, India, with a Ph.D. in Zoology. Her research expertise spans environmental science, parasitology, and biotechnology, focusing on issues such as environmental pollutants, mosquito repellent activity, and phytoremediation. Dr. Jameel’s work has practical applications in community health and environmental sustainability, including the use of plant extracts for mosquito control and soil contamination remediation.


Profile


Orcid


📚Education


She holds a Ph.D. in Zoology  from the Department of Zoology at the University of Lucknow. She completed her undergraduate studies with a Bachelor of Science (B.Sc.) in Zoology  from the University of Lucknow, maintaining a consistent first division  throughout her academic journey, from high school through to postgraduate studies.


🎓Professional Experience


    

  1. Research Personnel: Played a key role in organizing conferences and workshops, enhancing skills in academic networking and communication.
    2. 



2. Research Projects: Worked on projects linking natural products with cancer research, developing advanced skills in lipid extraction from fish muscles, GC-MS analysis, culture of cancer cell lines, and cytotoxicity assays.


3. Collaboration : Collaborated with the Department of Biochemistry at Era’s Medical College and Hospital, Lucknow.


 🧑‍🔬Research Focus


Diverse Research Topics:


    

  • Dr. Farheen Jameel has made significant contributions to various fields including environmental science, parasitology, and biotechnology.
    • 

  • His research on environmental pollutants, mosquito repellent activity, and phytoremediation directly impacts community health and environmental sustainability.
    • 



Geographic Impact:


    

  • Dr. Jameel’s research spans multiple regions, particularly India and Nigeria, addressing community-specific issues in different parts of the world.
    • 



Collaborative Efforts:


    

  • He has co-authored numerous papers with other researchers, highlighting his collaborative approach which is crucial for impactful, multidisciplinary research.
    • 



Applied Research:


    

  • His studies have practical applications, such as the use of plant extracts as mosquito repellents, phytoremediation techniques for soil contamination, and the use of natural products for antimicrobial activities, translating research into tangible community benefits.
    • 



Research and Innovations:


    

  • Completed/Ongoing Research Projects: UP-CST (Grant no. CST/375) on the study of PUFA in freshwater fish and their activity on cancer cell lines.
    • 



🏆Awards and Honors


Dr. Jameel has a substantial body of work published in peer-reviewed journals, indicating a high level of recognition in his field. His research is both innovative and impactful, aligning with the criteria for the Research for Community Impact Award.


Specific Projects and Publications


Environmental Health:


    

  • Dr. Jameel’s work on the assessment of heavy metals in aquatic ecosystems, like Clarias gariepinus in Nigeria, addresses public health concerns related to environmental contamination and food safety.
    • 



Vector Control:


    

  • His research on the mosquito repellent activity and larvicidal properties of plant extracts contributes to controlling vector-borne diseases, crucial for community health in tropical regions.
    • 



Waste Management and Water Quality:


    

  • Studies on the impact of solid waste dumping sites on groundwater quality and phytoremediation are essential for sustainable community living, addressing waste management and water pollution.
    • 



Parasitology and Infectious Diseases:


    

  • Extensive work in parasitology, including studies on gastrointestinal parasites in children and parasitic nematodes in insects, contributes to understanding and managing parasitic infections in communities.
    • 



📚🌍Publication Top Notes


    

  1. Synergistic anticancer effects of omega-3 Fatty acids (EPA/DHA) and anticancer drug Doxorubicin against human lung adenocarcinoma. Food Bioscience, 2024.
    2. 



2. Epidermal Mucus Extracts of three Freshwater Air Breathing Fish Species against Gram Positive and Gram Negative Human Pathogenic Bacteria. Indian Journal of Fisheries, 2019.


3. Omega-3 polyunsaturated fatty acids of fish and their role in cancerous cell lines: A review on in-vitro studies. Archives of Polish Fisheries, 2019.


4. Deficiency of protein, fat and vitamins in freshwater catfish, Clarias batrachus: morphological symptoms and impact on growth performance. Borneo Journal of Marine Science and Aquaculture, 2019.


5. Anticancer potency of skin mucus extract derived from Channa punctatus, Channa striatus, and Heteropneustes fossilis: An in-vitro analysis. Molecular and Cellular Biochemistry (under review).